SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001485003-22-000062
Filing Date
2022-05-09
Accepted
2022-05-09 08:01:46
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFA14A sesn-defa14a1q2022earnings.htm DEFA14A 33880
2 GRAPHIC sesn-form8xkwith1q2022ea001.jpg GRAPHIC 99756
3 GRAPHIC sesn-form8xkwith1q2022ea002.jpg GRAPHIC 96584
4 GRAPHIC sesn-form8xkwith1q2022ea003.jpg GRAPHIC 81915
5 GRAPHIC sesn-form8xkwith1q2022ea004.jpg GRAPHIC 42762
6 GRAPHIC sesn-form8xkwith1q2022ea005.jpg GRAPHIC 249010
7 sesn-form8xkwith1q2022ea006.jpg GRAPHIC 267867
8 sesn-form8xkwith1q2022ea007.jpg GRAPHIC 318792
9 sesn-form8xkwith1q2022ea008.jpg GRAPHIC 328608
10 sesn-form8xkwith1q2022ea009.jpg GRAPHIC 206109
11 sesn-form8xkwith1q2022ea010.jpg GRAPHIC 119948
12 GRAPHIC sesn-form8xkwith1q2022ea011.jpg GRAPHIC 94135
  Complete submission text file 0001485003-22-000062.txt   2660344
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 22903298
SIC: 2834 Pharmaceutical Preparations